CRISPR Therapeutics AG
看多

CRSP is bullish here, build up is enough to overcome downtrend

181
CRSP is bullish here, build is enough to overcome downtrend
RSI has been progressively gaining momentum

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。